title: Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation.
abstract: The aim of this study was to determine whether early changes in bone markers could predict long-term response in bone mineral density (BMD) after calcium (500 mg) and vitamin D (400 IU) supplementation twice daily in ambulatory elderly women with vitamin D insufficiency (25-hydroxyvitamin D, <12 ng/ml). One hundred and ninety-two women (mean age, 75 +/- 7 yr) were randomized to receive either the supplementation (n = 95) or a placebo (n = 97) in a double-blind, controlled clinical trial for 1 yr. In comparison with the placebo group, supplementation significantly increased BMD, normalized 25-hydroxyvitamin D and significantly decreased intact PTH and bone remodeling markers. The initial values of telopeptide cross-links were correlated with improvement in total body BMD [urinary N-telopeptides (NTX), r = 0.38; C-telopeptides (CTX), r = 0.32; serum CTX, r = 0.28], and the 3-month changes in the same markers were correlated with improvement in total body (urinary N-telopeptides, r = -0.29; serum CTX, r = -0.26) and vertebral BMD (CTX, r = -0.26; all P < 0.05). We concluded that short-term changes in bone resorption markers can predict long-term variations in BMD in elderly women with vitamin D insufficiency receiving calcium and vitamin D supplementation.
authors: Department of Rheumatology, CHU, Amiens 80054, France.
authors: Franck
authors: F
authors: Grados
authors: Michel
authors: M
authors: Brazier
authors: Saïd
authors: S
authors: Kamel
authors: Marc
authors: M
authors: Mathieu
authors: Nathalie
authors: N
authors: Hurtebize
authors: Mohamed
authors: M
authors: Maamer
authors: Michèle
authors: M
authors: Garabédian
authors: Jean-Luc
authors: JL
authors: Sebert
authors: Patrice
authors: P
authors: Fardellone
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers; D015519:Bone Density; D016723:Bone Remodeling / Q000187:drug effects*; D002118:Calcium / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D017698:Postmenopause; D011237:Predictive Value of Tests; D016896:Treatment Outcome; D014807:Vitamin D / Q000008:administration & dosage*; D014808:Vitamin D Deficiency / Q000188:drug therapy*
chemical_list: D015415:Biomarkers; D014807:Vitamin D; D002118:Calcium